Leukocyte Adhesion Deficiency

The Rare360 Editorial Team

Feb 192 min read

FDA Extends Priority Review Period for Kresladi/ RP-L 201 in Treating Severe Leukocyte Adhesion Deficiency-I (LAD-1)

Explore the FDA's extension of the priority review period for Kresladi, a groundbreaking gene therapy for severe LAD-1

The Rare360 Editorial Team

Jan 256 min read

Facing Leukocyte Adhesion Deficiency (LAD): Types, Symptoms, and Progress in Diagnosis and Treatment

Delve into Leukocyte Adhesion Deficiency (LAD): genetic causes, symptoms, and treatment strategies.